What Patients Should Know About Botox for Chronic Migraine

Botox (onabotulinumtoxinA) is an FDA-approved treatment specifically for chronic migraine in adults who experience 15 or more headache days per month, with at least 8 of those being migraine days. This prescription medication works differently from oral migraine medications by targeting nerve pathways involved in migraine pain.

The treatment involves injections administered by a healthcare provider every 12 weeks across specific areas of the head and neck. Patients typically receive 31 injections during each treatment session, targeting seven key muscle areas. The procedure is performed in a medical office and usually takes about 15 minutes to complete.

Clinical studies have shown that Botox can reduce the number of headache days per month for people with chronic migraine. Many patients begin to see improvement within 2-3 weeks after their first treatment, with continued improvement over multiple treatment cycles. The effects are temporary, which is why treatments need to be repeated every three months.

Common side effects may include neck pain, headache, and muscle weakness in the treatment area. Serious side effects are rare but can include difficulty swallowing, speaking, or breathing. Patients should discuss their complete medical history with their healthcare provider, including any medications they're taking and previous botulinum toxin treatments.

Before starting Botox for chronic migraine, patients should have a thorough evaluation to confirm their diagnosis and ensure this treatment approach is appropriate for their specific situation. Insurance coverage varies, and patients should check with their provider about coverage and any required prior authorizations.